Dr.ย Keun-Wookย Lee
M.D., M.S. (Internal Medicine), Ph.D. (Molecular Oncology)
Professor, Hematology & Medical Oncology | Chief Director, Comprehensive Cancer Center
corporate_fareSeoul National University Bundang Hospital, South Korea
Keun-Wook Lee
M.D., M.S. (Internal Medicine), Ph.D. (Molecular Oncology)
Prof. Keun-Wook Lee is a Professor of Internal Medicine and Chief Director of the Comprehensive Cancer Center at Seoul National University Bundang Hospital, one of South Korea's leading academic medical centres. He specialises in gastrointestinal cancers โ including gastric, colorectal, and gastroesophageal junction cancer โ as well as head and neck cancer, with a particular focus on chemotherapy and early-phase clinical trials.
Prof. Lee completed his M.D. at Seoul National University College of Medicine in 1998, followed by postgraduate training leading to an M.S. in Internal Medicine and a Ph.D. in Molecular Oncology from Seoul National University Graduate School. He has been based at Seoul National University Bundang Hospital since 2005, rising to Full Professor in 2018. He broadened his research expertise with a visiting professorship in the Department of Systems Biology at MD Anderson Cancer Center from 2012 to 2013. As of 2025, his official hospital profile credits him with more than 300 peer-reviewed scientific articles, and Seoul National University's research portal records 328 research outputs, 18,468 citations, and an h-index of 60. He currently also serves as Chief Director of the Clinical Trial Center at SNUBH, a role he has held since 2020.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert opinion from Prof. Lee at Seoul National University Bundang Hospital.
Why Consider Prof. Keun-Wook Lee?
Prof. Lee combines two decades of academic oncology with institutional leadership in clinical trials and cancer care, making him a highly relevant choice for patients with advanced gastric, gastrointestinal, and head and neck cancers.
Areas of Specialisation
Gastric, gastrointestinal, and head and neck cancer with systemic therapy and clinical trial expertise
Prof. Lee's clinical and research specialisation centres on gastrointestinal malignancies, including gastric, colorectal, and gastroesophageal junction cancers, alongside head and neck cancer. His practice integrates chemotherapy, early-phase clinical trials, and translational oncology research.
Gastric & Gastroesophageal Junction Cancer
Systemic therapy and trial-based treatment for advanced and metastatic gastric and GEJ cancers.
- arrow_rightPlatinum- and fluoropyrimidine-based chemotherapy protocols
- arrow_rightFOLFOX and mFOLFOX6 regimens for advanced gastric cancer
- arrow_rightCombination cytotoxic regimens for locally advanced and metastatic disease
- arrow_rightNivolumab plus chemotherapy in HER2-negative advanced gastric/GEJ cancer
- arrow_rightTislelizumab plus chemotherapy (RATIONALE-305)
- arrow_rightZanidatamab combined with tislelizumab and chemotherapy in HER2-positive GEJ adenocarcinoma
- arrow_rightBemarituzumab in FGFR2b-overexpressing gastric/GEJ cancer
- arrow_rightHER2-targeted therapy combinations
- arrow_rightBiomarker-guided treatment selection based on pathology and molecular profiling
Colorectal & Other GI Cancers
Medical oncology for colorectal cancer and other gastrointestinal malignancies.
- arrow_rightSystemic therapy planning for locally advanced and metastatic colorectal cancer
- arrow_rightChemotherapy and targeted agent combinations
- arrow_rightMedical oncology management of oesophageal and other GI cancers
- arrow_rightMultidisciplinary evaluation and systemic treatment planning
Head & Neck Cancer
Systemic treatment and chemotherapy for head and neck malignancies.
- arrow_rightChemotherapy-based treatment planning
- arrow_rightMedical oncology support within a multidisciplinary care framework
Early-Phase Clinical Trials & Translational Research
Phase I/II oncology trials and translational biomarker research at SNUBH's Clinical Trial Center.
- arrow_rightPhase I and II trials in gastrointestinal cancers
- arrow_rightFirst-line combination studies in gastric and GEJ adenocarcinoma
- arrow_rightCirculating tumour DNA (ctDNA) analysis in gastric cancer
- arrow_rightTranslational research on predictive and prognostic biomarkers
Procedures Performed
Systemic treatment and clinical research services in gastrointestinal and head and neck oncology
Prof. Lee's procedural practice covers the full spectrum of medical oncology for gastric, colorectal, gastroesophageal junction, and head and neck cancers โ from chemotherapy administration to trial enrolment and translational research.
Chemotherapy Administration
Medical OncologySystemic chemotherapy protocols for gastric, colorectal, and other gastrointestinal cancers.
Immunotherapy & Targeted Therapy
Targeted TherapyCheckpoint inhibitor and molecularly targeted treatment combinations for eligible patients.
Clinical Trial Enrolment & Management
Complex DiseaseEarly-phase and phase III oncology trial participation for eligible patients at the SNUBH Clinical Trial Center.
Diagnostic Evaluation & Molecular Profiling
DiagnosisStaging work-up and molecular profiling to guide systemic treatment selection.
Second Opinion in Gastrointestinal Oncology
Second OpinionEvidence-based review of cases and treatment plans for patients with gastric, colorectal, and GEJ cancers.
Research & Publications
Gastrointestinal oncology research, clinical trials, and translational science
Prof. Lee has published more than 300 peer-reviewed scientific articles with an h-index of 60 and over 18,000 citations (Scopus, as recorded by Seoul National University). His research focuses on gastric and gastroesophageal junction cancer, colorectal cancer, immunotherapy combinations, targeted therapy, and liquid biopsy.
Prof. Lee maintains an active publication record. A full list of his peer-reviewed papers is available through Seoul National University's research portal and PubMed.
Education & Training
Prof. Lee trained entirely at Seoul National University, completing his M.D., M.S., and Ph.D. before pursuing clinical fellowship and subspecialty training in haematology-oncology.
Clinical Experience
Prof. Lee has spent his entire academic career at Seoul National University Bundang Hospital, progressing from clinical professor in 2005 to full professor in 2018, and assuming successive leadership roles including Chief of the Division of Haematology-Oncology, Chief Director of the Clinical Trial Center, and Chief Director of the Comprehensive Cancer Center.
Languages & International
Prof. Lee consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting with Prof. Lee.
CancerFax can coordinate professional medical interpreter support for international patients requiring communication assistance.
How CancerFax Helps You Access Dr. Keun-Wook Lee
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Keun-Wook Lee's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Keun-Wook Lee's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Keun-Wook Lee before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Keun-Wook Lee's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Keun-Wook Lee's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Keun-Wook Lee's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Keun-Wook Lee
Prof. Lee specialises in gastrointestinal cancers โ including gastric cancer, gastroesophageal junction cancer, and colorectal cancer โ as well as head and neck cancer. His clinical and research work has a particular focus on advanced and metastatic gastric cancer, systemic therapy combinations, and biomarker-driven treatment selection.
Prof. Lee is based at Seoul National University Bundang Hospital (SNUBH) in Seongnam, South Korea. He is a Professor of Internal Medicine in the Division of Hematology and Medical Oncology, and currently serves as Chief Director of the Comprehensive Cancer Center and Chief Director of the Clinical Trial Center at SNUBH.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert opinion from Prof. Lee at Seoul National University Bundang Hospital, subject to hospital availability and case acceptance. Please submit your reports through CancerFax for an initial review.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the hospital, subject to availability and case suitability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. Prof. Lee's expertise in gastric and gastrointestinal cancer treatment planning makes him particularly well-placed for complex second-opinion cases. The final format and availability depend on the doctor's institution.
Yes. Prof. Lee serves as Chief Director of the Clinical Trial Center at Seoul National University Bundang Hospital and his official hospital profile lists chemotherapy clinical trials and early-phase clinical trials among his core areas of work. His recent trial involvement includes studies of nivolumab, tislelizumab, bemarituzumab, and zanidatamab in gastric and gastroesophageal junction cancers. Trial eligibility is assessed on an individual basis by the treating team.
Connect with Keun-Wook Lee Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.